HOME | CONTACT | BLOG | SITE MAP   

Press Releases

New Patent for Adipose Stem Cells Issued to VetStem Biopharma

VetStem Biopharma issued patent that covers methods for extracting/preparing and using adipose tissue-derived stem cells for musculoskeletal injury in any mammal, including humans

August 15, 2016 --

VetStem Biopharma, Inc., announced that a major United States patent has been issued directly to VetStem.  This patent covers methods for extracting/preparing and using adipose tissue-derived stem cells for preventing or treating inflammation at site of musculoskeletal injury in any mammal, including humans.  This patent will provide coverage for the on-going commercial and development programs at VetStem and may be available for licensing to other companies interested in working in this field.   VetStem already received issuance of a similar patent for the EU in 2014 and has similar patent applications pending in other countries. 

 

This new patent issued to VetStem adds to the other patents in the VetStem portfolio that cover methods of using regenerative cells from adipose tissue for the eye, pancreas, liver, bone and muscle. VetStem has exclusive worldwide rights for veterinary use of these other licensed patents (over 55 issued and 70 pending patents) and this strengthens further the company’s intellectual property position in this rapidly developing field. 

 

As the first company in the world to offer fat derived stem cell services for veterinary use, VetStem has rapidly developed the market, providing treatments to over 12,000 horses, dogs, cats and exotic species.  “Intellectual property rights are critical and can be confusing in a rapidly developing market with evolving technology.” said Bob Harman, DVM, MPVM, CEO of VetStem. “We have taken appropriate actions to protect the market that we are creating in regenerative veterinary medicine and to ensure that the value of the company is optimized.  The value of this technology has increased greatly since the founding of the company in 2002 as the business model, therapeutic activity of the cells, and ease of tissue collection have all been demonstrated.”

 





< Back to Press Releases     

 


  • Success Stories
    News
    Videos
    Blog
    Press Releases
    Facebook
    Twitter
     


      COMPANY
    Management
    Investors
    Contact Us
    Careers
    SCIENCE
    FAQs
    Literature Refs
    Safety
    PET & HORSE OWNERS
    Dogs & Cats
    Horses
    Locate a Vet
    FAQs
    VETERINARIANS
    Vet Login /
    Credentialing

    Dogs & Cats
    Horses
    FAQs
    MEDIA ROOM
    Press Releases
    Success Stories
    News
    Videos
    Blog
    LOCATE A VET

    CONTACT US
     

    COPYRIGHT 2011 VETSTEM BIOPHARMA. ALL RIGHTS RESERVED.
    12860 Danielson Court, Suite B, Poway, CA 92064 Phone: 858-748-2004 or 888-387-8361